1. Home
  2. GLMD vs MLEC Comparison

GLMD vs MLEC Comparison

Compare GLMD & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Galmed Pharmaceuticals Ltd.

GLMD

Galmed Pharmaceuticals Ltd.

HOLD

Current Price

$0.60

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$8.20

Market Cap

4.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLMD
MLEC
Founded
2000
2008
Country
Israel
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.4M
4.7M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
GLMD
MLEC
Price
$0.60
$8.20
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
35.2K
216.6K
Earning Date
04-02-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.42
Revenue Next Year
N/A
$30.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.21
52 Week High
$2.67
$23.22

Technical Indicators

Market Signals
Indicator
GLMD
MLEC
Relative Strength Index (RSI) 40.69 42.05
Support Level $0.50 $0.60
Resistance Level $0.69 $12.69
Average True Range (ATR) 0.05 1.17
MACD 0.00 -0.50
Stochastic Oscillator 15.65 12.99

Price Performance

Historical Comparison
GLMD
MLEC

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

Share on Social Networks: